In this Special Report, we highlight notable trends in antitrust litigation involving health care providers over the past two and a half years. Our complimentary update identifies the types of cases filed against providers, who is filing them, case results and currently pending cases to watch.
Antitrust Litigation Update for Health Care Providers
By Katharine M. O'Connor and Stephen Wu on June 25, 2018
Katharine M. O'ConnorKatharine O’Connor focuses her practice on complex antitrust litigation, government investigations, defending mergers and acquisitions before antitrust enforcement agencies, and counseling clients on antitrust compliance issues. She has experience representing clients in a wide array of industries, including health care, manufacturing, food and finance. Read Katharine O’Connor's full bio.
Stephen WuStephen Wu focuses his practice on antitrust litigation, defending mergers and acquisitions before antitrust enforcement agencies and counseling clients on antitrust compliance issues. He represents clients in a wide variety of industries ranging from aerospace to consumer products and food, with a particular concentration on health care antitrust matters. He is co-chair of the Firm’s Health Antitrust Affinity Group. Read Stephen Wu's full bio.
Related Posts
- 2020 Health Antitrust Year in Review
- Health Antitrust Litigation Update for Providers | 2020
- Antitrust Litigation Update for Health Care Providers
- Executive Order Encourages FTC, DOJ to Address Hospital Consolidation, Vigorously Enforce Antitrust Laws
- California Attorney General Announces Historic $575 Million Settlement of Antitrust Suit Against Sutter Health
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- US Federal Agencies Commit to Regulatory Enforcement of AI Systems
- Going ‘Green’—What Does That Mean? FTC Proposes Revisions to Green Guides
- EU Commission Adopts New Merger Simplification Package
- CMA Blocks Microsoft’s Acquisition of Activision Blizzard; ‘Game Over’ for Behavioral Remedies?
- DOJ’s Labor Market Prosecution Against Aerospace Employees Dismissed; Alleged Market Allocation Not Within Per Se Rule
